IP36-20: Homozygosity of Killer Immunoglobulin-Like Receptors A Haplotype Is Associated With Clinical Outcomes in Patients With Urothelial Cancer Treated With Pembrolizumab

IP36-20: Homozygosity of Killer Immunoglobulin-Like Receptors A Haplotype Is Associated With Clinical Outcomes in Patients With Urothelial Cancer Treated With Pembrolizumab

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!